Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/2003
07/15/2003US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/15/2003US6593294 Coagulation factor VIII and substantially neutral colloidal particles comprising 1-20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer for treatment of hemophilia
07/15/2003US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization
07/15/2003US6592910 Methods of treating clinical diseases with isoflavones
07/15/2003US6592902 Controlled release eplerenone compositions
07/15/2003US6592868 Produced by hybridoma having ATCC Accession Number HB 10916
07/15/2003CA2067408C 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
07/10/2003WO2003055989A2 Cellular compositions and methods of making and using them
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055881A1 Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055863A1 Novel alkansulfonamides as endothelin antagonists
07/10/2003WO2003055531A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
07/10/2003WO2003055516A1 Pecam-1 modulation
07/10/2003WO2003055512A1 Liquid composition of factor vii polypeptides
07/10/2003WO2003055511A1 Liquid composition of modified factor vii polypeptides
07/10/2003WO2003055499A1 Use of sulfated glycosaminoglycans for establishing effective labor in women
07/10/2003WO2003055476A1 Use of succinic acid and salts thereof for inhibiting platelet aggregation
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003035670A3 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
07/10/2003WO2003027245A3 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
07/10/2003WO2002079778A3 In vivo delivery methods and compositions
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002009761A9 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130270 Heterocyclic derivatives and their use as antithrombotic agents
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130250 Methods to mobilize progenitor/stem cells
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130203 Sleep disorders
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129663 Methods and compositions for modulating oxidized ldl transport
07/10/2003US20030129186 Compositions and methods for modulating blood-brain barrier transport
07/10/2003US20030129166 Human circulating dendritic cell compositions and methods
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2470707A1 Cellular compositions and methods of making and using them
07/10/2003CA2470696A1 Pecam-1 modulation
07/10/2003CA2470684A1 A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2470511A1 Liquid composition of factor vii polypeptides
07/10/2003CA2470313A1 Liquid composition of modified factor vii polypeptides
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325914A1 Tetrahydroquinoline compounds
07/09/2003EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325008A1 Piperazine derivatives
07/09/2003EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
07/09/2003EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
07/09/2003EP1324994A2 Tricyclic compounds and uses thereof
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324759A2 Nf-g(k)b inhibitors
07/09/2003EP0988316A4 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
07/09/2003EP0988056B1 Tissue factor methods and compositions for coagulation and tumor treatment
07/09/2003EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE
07/09/2003CN1429202A Compounds for modulating cell proliferation
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1429117A Pharmaceutical composition comprising factor VIIa and factor XIII
07/09/2003CN1429116A Pharmaceutical composition
07/09/2003CN1429073A A gene therapy system and method using alpha-MSH and its derivatives
07/09/2003CN1428173A Recombinant hirudin oral enteric soluble slowly-releasing preparation
07/09/2003CN1428169A Blood-supplementing blood-nourishing pure Chinese medicine preparation, preparation process and application
07/09/2003CN1428156A Capsule for curing aplastic anemia and its production method
07/09/2003CN1428147A New medicine for curing cerebral thrombosis
07/09/2003CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline
07/09/2003CN1113664C Preparation of hematopoietic tortoise-deer capsule
07/09/2003CN1113655C Oxygen-reduced solidifying factor VIII aqueous solution
07/09/2003CN1113654C Compounds and pharmaceutical compositions containing them
07/09/2003CN1113646C Medicinal preparation containing shikimic acid and its derivatives, and its use in preparing anti-thrombosis and analgesic medicine
07/08/2003US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
07/08/2003US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
07/08/2003US6589984 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as
07/08/2003US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell
07/08/2003US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
07/08/2003US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist.
07/08/2003US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample
07/08/2003US6589286 Eustachian tube stent
07/08/2003US6589223 Method and compositions for use in perfusion applications
07/08/2003CA2133646C Stem cell proliferation factor
07/03/2003WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors
07/03/2003WO2003054020A2 Human antibodies against human glycoprotein vi and their use
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053997A2 Methods of increasing endogenous erythropoietin (epo)
07/03/2003WO2003053969A1 Imidazoquinoline derivatives
1 ... 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 ... 671